C-Met, a receptor for hepatocyte growth factor (HGF), experiences overexpression in up to 40% of HCC patients and is localized both on the cytomembrane and mitochondria (Guo et al. 2010; Yakes et al. 2011). The gene discussed is MET; the disease is hepatocellular carcinoma.